Seres Therapeutics (MCRB) Inventory Average (2023 - 2024)
Seres Therapeutics (MCRB) posted Inventory Average of $47.5 million for Q2 2024, up 32.6% sequentially from $35.8 million in Q1 2024.
Seres Therapeutics (MCRB) Inventory Average (2023 - 2024) Analysis & Trends
Seres Therapeutics has reported Inventory Average for 2 years, with the latest figure at $47.5 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.41 Bn | 130.56 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.41 Bn | 59.23 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.56 Bn | 52.43 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 42.06 Bn | 36.96 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.95 Bn | 27.65 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 27.48 Bn | 9.09 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.31 Bn | 26.15 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.04 Bn | 26.20 Bn | - | - |
| 10 | Seres Therapeutics | 43.87 Mn | 43.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 47.49 Mn |
| Mar 31, 2024 | 35.81 Mn |
| Dec 31, 2023 | 24.09 Mn |
| Sep 30, 2023 | 11.93 Mn |